Optimization of Thulium Fiber Laser Lithotripsy Efficacy Based on Multidimensional Parameter Combination Strategies [0.03%]
基于多维参数组合策略的铥纤维激光碎石效率优化研究
Zhilong Li,Xiaoyu Tang,Shaoxi Liu et al.
Zhilong Li et al.
Background and objective: This study marks the first systematic evaluation of how various parameter combinations in domestic thulium fiber lasers (TFLs) influence the efficacy of urinary stone lithotripsy. ...
Incorporating Lower Urinary Tract Symptoms to Predict the Risk of Positive Prostate Magnetic Resonance Imaging [0.03%]
结合下尿路症状预测阳性前列腺磁共振影像的风险
Leonor Jane Paulino Pereira,Harm H E van Melick,Michiel J P M Sedelaar et al.
Leonor Jane Paulino Pereira et al.
Background and objective: Many men referred from primary care entering magnetic resonance imaging (MRI)-based prostate cancer (PCa) pathways have an MRI without abnormalities, highlighting the need to improve MRI risk str...
Early Efficacy and Exploratory Biomarker Data of Bel-sar in Patients with Intermediate-risk and High-risk Non-muscle-invasive Bladder Cancer [0.03%]
Bel-sar治疗中高危NMIBC患者的早期疗效及探索性生物标志物分析
Jennifer Linehan,Piyush K Agarwal,Xianne Penny et al.
Jennifer Linehan et al.
Background and objective: Despite available therapies, patients with non-muscle-invasive bladder cancer (NMIBC) are impacted by recurrence and progression risk. Bel-sar (belzupacap sarotalocan) is a first-in-class virus-l...
Long-term Outcomes in Men with Stable PSA During 5-α Reductase Inhibitor Therapy After Negative Prostate Biopsy: Population-based Study [0.03%]
一项基于人群的研究：负前列腺活检后长期服用5-α还原酶抑制剂期间PSA稳定的男性的预后分析
Eugenio Ventimiglia,Marcus Westerberg,Andri Wilberg Orasson et al.
Eugenio Ventimiglia et al.
Evidence on long-term outcomes after a negative biopsy, particularly prostate cancer mortality, remains limited, and optimal follow-up strategies are unclear. This nationwide population-based study assessed whether prostate-specific antigen...
Corrigendum to "Long-term real-world survival outcomes with dual immune checkpoint blockade in synchronous metastatic renal cell carcinoma: implications for the design of prospective cytoreductive nephrectomy trials" [Eur. Urol. Open Sci. 83 (2026) 133-141] [0.03%]
“双免疫检查点抑制同步转移性肾细胞癌的长期真实世界生存结局：对前瞻性去势肾切除术试验设计的意义”一文的勘误函
Leo Bickley,Elisabeth E Fransen van de Putte,Luna van den Brink et al.
Leo Bickley et al.
[This corrects the article DOI: 10.1016/j.euros.2025.12.004.]. © 2026 The Author(s).
Published Erratum
European urology open science. 2026 Jun 6:89:71. DOI:10.1016/j.euros.2026.05.009 2026
Pulmonary Fibrosis and Pulmonary Function in Patients with Metastatic Testicular Cancer During and after Combination Chemotherapy: The BLEOTOX Study [0.03%]
睾丸癌转移患者在接受联合化疗期间和之后的肺纤维化及肺功能：BLEOTOX研究
Lisa Frey,Salma Grunwald,Christian Ruckes et al.
Lisa Frey et al.
Background and objective: Metastatic testicular germ cell tumors (mTGCTs) are treated with combination chemotherapy (Cx) containing bleomycin (BEP [bleomycin, etoposide, and cisplatin]). Bleomycin-induced pulmonary toxici...
PSA Response as a Prognostic Marker in Metastatic Hormone-sensitive Prostate Cancer: Comparison with Tumor Volume (CHAARTED) [0.03%]
转移性激素敏感型前列腺癌中预测预后指标的新标志：PSA反应与肿瘤体积的比较(CHAARTED研究)
Rocío Martínez-Corral,Pedro De Pablos-Rodríguez,Sergio Antón-Fuente et al.
Rocío Martínez-Corral et al.
Background and objective: Tumor volume and prostate-specific antigen (PSA) response (PSAr) are among the most relevant clinical prognostic factors in metastatic hormone-sensitive prostate cancer (mHSPC). However, their co...
Survival Outcomes of Patients with Treated vs Actively Surveilled Bosniak III or IV Kidney Cysts: A Systematic Review [0.03%]
对III型或IV型肾囊肿治疗与观察患者的生存结局进行的系统评价
Carla Chehadeh,Vikas Burugu,Paul E Andrews et al.
Carla Chehadeh et al.
Background and objective: Bosniak III and IV kidney cysts have high malignancy rates, and treatment is often recommended. However, evidence suggests active surveillance (AS) may achieve similar cancer-specific survival (C...
Optimizing the Diagnosis of Interstitial Cystitis/Bladder Pain Syndrome: An ESSIC Proposal [0.03%]
间质性膀胱炎/膀胱疼痛综合征诊断的优化：ESSIC建议
Sachin Malde,Yoshiyuki Akiyama,Dick Janssen et al.
Sachin Malde et al.
Background and objective: Interstitial cystitis/bladder pain syndrome (IC/BPS) is a heterogenous symptom syndrome. Patients are often misdiagnosed, and current treatment algorithms do not promote an individualized approac...
Progression-free Survival Following Primary Staging with [18F]PSMA-1007-PET/ceCT Versus Na[18F]F-PET/ceCT in Prostate Cancer: Results from the PRISMA-PET Randomized Controlled Trial [0.03%]
[18F]PSMA-1007-PET/ceCT与Na[18F]F-PET/ceCT作为前列腺癌初始分期对无进展生存的影响：PRISMA-PET随机对照试验的结果
Karen M Buch-Olsen,Steinbjørn Hansen,Mie H Vilstrup et al.
Karen M Buch-Olsen et al.
Objective: To compare progression-free survival (PFS) in newly diagnosed prostate cancer (PCa) staged with prostate-specific membrane antigen prostate-specific membrane antigen 1007 ([18F]PSMA-1007)-positron emission tomo...